Desafios e perspectivas para prevenção e tratamento da obesidade*
Referências
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(1040):2133-61. PMID: 38642570; https://doi.org/10.1016/s0140-6736(24)00757-8.
Syn NL, Cummings DE, Wang LZ, et al. Association of metabolicbariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830-41. PMID: 33965067; https://doi.org/10.1016/s0140-6736(21)00591-2.
Instituto de Estudos de Saúde Suplementar. Como o aumento da prevalência da obesidade entre beneficiários pode impactar
a sustentabilidade da saúde suplementar. São Paulo: IESS; 2022. Available from: https://www.iess.org.br/sites/default/files/2022-06/
Obesidade_Cen%C3%A1rios%20para%20o%20Futuro.pdf. Accessed in 2024 (Jun. 14).
Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes. 2009;33(3):289-95. PMID: 19188927; https://doi.org/10.1038/ijo.2009.2.
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Obes Surg. 2023;33(1):3-14. PMID: 36336720; https://doi.org/10.1007/s11695-022-06332-1.
